// App-Quantinova.ai

LB1029 : Correlation of merkel virus-specific CD8 T cells with response to immunotherapy in merkel cell carcinoma

Researchers

Presenter

  • T. Pulliam

Principal Investigators

  • S. Jani

  • L. Jing

  • J. Zhang

  • R. Kulikauskas

  • C. Church

  • C. Garnett-Benson

  • K. Paulson

  • D. Pardoll

  • D. Koelle

  • S. Topalian

  • P. Nghiem

Medical Centers

  • Biostatistics, University of Washington, Seattle, Washington, United States

  • Swedish Cancer Institute, Seattle, Washington, United States

  • Bristol-Myers Squibb Co, New York, New York, United States

  • Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Merkel cell carcinoma

  • Solid malignancies

Biomarkers

  • Cluster of differentiation 8A

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02488759

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved